FindTrial
Sign In

Efficacy of esketamine combined with ropivacaine in fascia iliaca compartment block for perioperative analgesia in hip surgery

Study on Perioperative Analgesia with Esketamine Combined with Ropivacaine in Fascia Iliaca Compartment Block for Hip Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116937
Enrollment
Unknown
Registered
2026-01-16
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Group E:Patients in Group E received fascia iliaca compartment block with esketamine combined with low-concentration ropivacaine.
Group R:Patients in Group R received fascia iliaca compartment block with low-concentration ropivacaine.

Sponsors

Liuzhou workers' hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 60 and 80 years old; 2. Surgical method is total hip arthroplasty; 3. ASA classification II-III; 4. Obtain the patient's informed consent and have them sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Infection at the puncture site, allergy to local anesthetics, coagulation disorders; 2. Liver or kidney failure; 3. Use of analgesics before surgery; 4. History of chronic pain or opioid abuse; 5. Mental illness; 6. Pregnant or breastfeeding women; 7. Patients who refuse to participate; 8. Other individuals unsuitable for clinical trials; 9. Patients undergoing repeat hip surgery on the same side.

Design outcomes

Primary

MeasureTime frame
NRS (Numeric Rating Scale)scores;QoR-15 (15-item Quality of Recovery score);—

Countries

China

Contacts

Public ContactSenlin Li

Liuzhou workers' hospital

lisenlinwenzhou@163.com+86 135 9702 2352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026